Semaglutide's gastrointestinal effects vary by product and dose: nausea (20-44%), vomiting (9-24%), and diarrhea (9-30%) according to FDA prescribing information
This serum promises to deliver just that, thanks to ingredients like copper peptides, squalane and hyaluronic acid
Gerbe F, Legraverend C, Jay P
Most people can eat relatively normally at this dose, so focus on habit formation rather than restriction
As of April 2025, retatrutide is not approved for clinical use in the United Kingdom
The FDA commented on phrases used in the commercial, including live lighter and a way forward that, in the agencys view, imply added benefits compared to other treatments, despite no evidence to support those claims